{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:05Z","timestamp":1761663125814,"version":"3.40.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T00:00:00Z","timestamp":1355443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00296-012-2591-1","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T05:48:08Z","timestamp":1355377688000},"page":"1487-1494","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis"],"prefix":"10.1007","volume":"33","author":[{"given":"Shereem Mohamed","family":"Olama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Mohamed","family":"Elarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(94)92211-X","volume":"344","author":"B Halliwell","year":"1994","unstructured":"Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721\u2013724","journal-title":"Lancet"},{"key":"2591_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0009-9120(96)00007-0","volume":"30","author":"JK Gambhir","year":"1997","unstructured":"Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351\u2013355","journal-title":"Clin Biochem"},{"key":"2591_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.nu.16.070196.000341","volume":"16","author":"B Halliwell","year":"1996","unstructured":"Halliwell B (1996) Antioxidants in human health and disease. Annu Rev Nutr 16:33\u201350","journal-title":"Annu Rev Nutr"},{"key":"2591_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/cs1010593","volume":"101","author":"I Mazzetti","year":"2001","unstructured":"Mazzetti I, Grigolo B, Pulsatelli L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond) 101:593\u2013599","journal-title":"Clin Sci (Lond)"},{"key":"2591_CR5","first-page":"7","volume":"45","author":"K Hadjigogos","year":"2003","unstructured":"Hadjigogos K (2003) The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 45:7\u201313","journal-title":"Panminerva Med"},{"key":"2591_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00041433-199604000-00004","volume":"7","author":"MI Mackness","year":"1996","unstructured":"Mackness MI, Mackness B, Durrington PN, Connelly PW et al (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69\u201376","journal-title":"Curr Opin Lipidol"},{"key":"2591_CR7","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI1649","volume":"101","author":"M Aviram","year":"1998","unstructured":"Aviram M, Rosenblat M, Bisgaier CL, Newton RS et al (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581\u20131590","journal-title":"J Clin Invest"},{"key":"2591_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","volume":"139","author":"KR Feingold","year":"1998","unstructured":"Feingold KR, Memon RA, Moser AH, Grunfeld C (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139:307\u2013315","journal-title":"Atherosclerosis"},{"key":"2591_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-5793(98)00064-7","volume":"423","author":"B Mackness","year":"1998","unstructured":"Mackness B, Mackness MI, Arrol S, Turkie W et al (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57\u201360","journal-title":"FEBS Lett"},{"key":"2591_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0891-5849(02)01429-6","volume":"34","author":"O Rozenberg","year":"2003","unstructured":"Rozenberg O, Rosenblat M, Coleman R, Shih DM et al (2003) Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 34:774\u2013784","journal-title":"Free Radic Biol Med"},{"key":"2591_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00008571-199110000-00009","volume":"1","author":"A Karakaya","year":"1991","unstructured":"Karakaya A, Suzen S, Sardas S, Karakaya AE, Vural N (1991) Analysis of the serum paraoxonase\/arylesterase polymorphism in a Turkish population. Pharmacogenetics 1:58\u201361","journal-title":"Pharmacogenetics"},{"key":"2591_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.clinbiochem.2006.02.004","volume":"39","author":"Z Serdar","year":"2006","unstructured":"Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A (2006) Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 39:794\u2013803","journal-title":"Clin Biochem"},{"key":"2591_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2407-7-48","volume":"7","author":"ET Elkiran","year":"2007","unstructured":"Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S (2007) Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 7:48\u201355","journal-title":"BMC Cancer"},{"key":"2591_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","volume":"19","author":"KN Gan","year":"1991","unstructured":"Gan KN, Smolen A, Eckerson HW, La Du BN (1991) Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19:100\u2013106","journal-title":"Drug Metab Dispos"},{"key":"2591_CR15","first-page":"2853","volume":"69","author":"RK Kataria","year":"2004","unstructured":"Kataria RK, Brent LH (2004) Spondyloarthropathies. Am Fam Physician 69:2853\u20132860","journal-title":"Am Fam Physician"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00296-007-0352-3","volume":"27","author":"M Karakoc","year":"2007","unstructured":"Karakoc M, Altindag O, Keles H, Soran N, Selek S (2007) Serum oxidative\u2013antioxidative status in patients with ankylosing spondilitis. Rheumatol Int 27:1131\u20131134","journal-title":"Rheumatol Int"},{"issue":"2","key":"2591_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1590\/S1807-59322010000200009","volume":"65","author":"FH Erdem","year":"2010","unstructured":"Erdem FH, Karatay S, Yildirim K, Kiziltunc A (2010) Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics 65(2):175\u2013179","journal-title":"Clinics"},{"issue":"4","key":"2591_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361\u2013368","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2591_CR19","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286\u20132291","journal-title":"J Rheumatol"},{"key":"2591_CR20","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"2591_CR21","first-page":"1126","volume":"35","author":"HW Eckerson","year":"1983","unstructured":"Eckerson HW, Wyte MC, La Du BN (1983) The human serum paraoxonase\/arylesterase polymorphism. Am J Hum Genet 35:1126\u20131138","journal-title":"Am J Hum Genet"},{"key":"2591_CR22","first-page":"391","volume":"30","author":"L Haagen","year":"1992","unstructured":"Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 30:391\u2013395","journal-title":"Eur J Clin Chem Clim Biochem"},{"key":"2591_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohisi N, Yagi K (1979) Assay for peroxides in animal tissue by thiobarbituric acid reaction. Ann Biochem 95:351\u2013358","journal-title":"Ann Biochem"},{"key":"2591_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","volume":"21","author":"ST Reddy","year":"2001","unstructured":"Reddy ST, Wadleigh DJ, Grijalva V et al (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542\u2013547","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"suppl 1","key":"2591_CR25","doi-asserted-by":"publisher","first-page":"261S","DOI":"10.1093\/ajcn\/81.1.261S","volume":"81","author":"AR Collins","year":"2005","unstructured":"Collins AR (2005) Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 81(suppl 1):261S\u2013267S","journal-title":"Am J Clin Nutr"},{"key":"2591_CR26","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/S0024-3205(03)00195-4","volume":"72","author":"N Tanimoto","year":"2003","unstructured":"Tanimoto N, Kumon Y, Suehiro T, Ohkubo S et al (2003) Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 72:2877\u20132885","journal-title":"Life Sci"},{"key":"2591_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.clinbiochem.2005.06.010","volume":"38","author":"G Baskol","year":"2005","unstructured":"Baskol G, Demir H, Baskol M, Kilic E et al (2005) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38:951\u2013955","journal-title":"Clin Biochem"},{"key":"2591_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/rheumatology\/keg194","volume":"42","author":"S Ozgocmen","year":"2003","unstructured":"Ozgocmen S, Sogut S, Fad\u0131ll\u0131oglu E, Ardicoglu A, Ardicoglu O (2003) Antioxidant status and lipid peroxidation in seminal plasma and spermatozoa of patients with ankylosing spondylitis. Rheumatology 42:805\u2013807","journal-title":"Rheumatology"},{"key":"2591_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00296-003-0335-y","volume":"24","author":"S Ozgocmen","year":"2004","unstructured":"Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80\u201383","journal-title":"Rheumatol Int"},{"issue":"6","key":"2591_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.clinbiochem.2009.12.019","volume":"43","author":"A Stanek","year":"2010","unstructured":"Stanek A, Cie\u015blar G, Romuk E, Kasperczyk S, Siero\u0144-Sto\u0142tny K, Birkner E, Siero\u0144 A (2010) Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis. Clin Biochem 43(6):566\u2013570 (epub 4 Jan 2010)","journal-title":"Clin Biochem"},{"issue":"4","key":"2591_CR31","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.25011\/cim.v34i4.15364","volume":"34","author":"H Cece","year":"2011","unstructured":"Cece H, Yazgan P, Karakas E, Karakas O, Demirkol A, Toru I, Aksoy N (2011) Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis. Clin Invest Med 34(4):E225","journal-title":"Clin Invest Med"},{"key":"2591_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0025-7753(03)74011-1","volume":"121","author":"A Canales","year":"2003","unstructured":"Canales A, Sanchez-Muniz FJ (2003) Paraoxanase, something more than an enzyme? Med Clin (Barc) 121:537\u2013548 (Spanish)","journal-title":"Med Clin (Barc)"},{"key":"2591_CR33","doi-asserted-by":"publisher","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","volume":"272","author":"D Steinberg","year":"1997","unstructured":"Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963\u201320966","journal-title":"J Biol Chem"},{"key":"2591_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1515\/CCLM.1998.073","volume":"37","author":"PM Laplaud","year":"1998","unstructured":"Laplaud PM, Dantoine T, Chapman MJ (1998) Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses. Clin Chem Lab Med 37:431\u2013441","journal-title":"Clin Chem Lab Med"},{"key":"2591_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1515\/CCLM.2005.177","volume":"43","author":"H Jakubowski","year":"2005","unstructured":"Jakubowski H (2005) Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease. Clin Chem Lab Med 43:1011\u20131014","journal-title":"Clin Chem Lab Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2591-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2591-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:18:11Z","timestamp":1745425091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2591-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,14]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2591-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2012,12,14]]}}}